A single center audit comparing the switch from darbepoetin alfa to an epoetin alfa biosimilar and backwards in hemodialysis patients

被引：0
|
作者：
Jungbluth, H.
Haegele, B.
机构：
来源：
SWISS MEDICAL WEEKLY | 2010年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：21S / 22S
页数：2
相关论文
共 50 条
  • [21] Development of a strategy to successfully convert an ambulatory infusion center from procrit (epoetin alfa) to aranesp (darbepoetin alfa).
    Longfield, V
    Gebhart, B
    Hayward, L
    ONCOLOGY NURSING FORUM, 2005, 32 (02) : 470 - 470
  • [22] Retrospective study of the appropriate utilization of epoetin alfa and darbepoetin alfa in cancer patients with anemia
    Wong, SF
    Brown, ML
    Sarkisian, R
    PHARMACOTHERAPY, 2004, 24 (10): : 1452 - 1452
  • [23] Utilization of epoetin alfa (EPO) and darbepoetin alfa (DARB) in critically ill patients.
    Mody, S.
    Watson, S.
    McKenzie, R. S.
    Raut, M.
    CRITICAL CARE MEDICINE, 2006, 34 (12) : A131 - A131
  • [24] Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease
    Chen, Han-Hsiang
    Tarng, Der-Cherng
    Lee, Kun-Feng
    Wu, Chih-Jen
    Chen, Yi-Chou
    JOURNAL OF NEPHROLOGY, 2008, 21 (04) : 543 - 549
  • [25] Haemoglobin fluctuations in haemodialysis patients receiving intravenous epoetin alfa or intravenous darbepoetin alfa
    Walker, R.
    Pussell, B. A.
    VALUE IN HEALTH, 2007, 10 (03) : A103 - A103
  • [26] Comparative Efficacy and Safety Study of Darbepoetin Alfa versus Epoetin Alfa in Management of Anemia Associated with ESRD in Egyptian Hemodialysis Patients
    El-Ashmawy, Nahla E.
    Khedr, Eman G.
    Kotb, Nahla S.
    Salem, Fathi
    Ibrahim, Amera O.
    CURRENT DRUG SAFETY, 2022, 17 (03) : 250 - 258
  • [27] Comparison of hemoglobin response in hospitalized hemodialysis patients receiving either epoetin alfa or darbepoetin alfa in an integrated health care system
    Lew, I
    Adamson, R
    PHARMACOTHERAPY, 2004, 24 (10): : 1446 - 1447
  • [28] Switch of ESA therapy from darbepoetin-α to epoetin-β in hemodialysis patients:: a single-center experience
    Biggar, P.
    Ketteler, M.
    Hennernann, H.
    Doemling, R.
    CLINICAL NEPHROLOGY, 2008, 69 (03) : 185 - 192
  • [29] Standardized doses of epoetin alfa for hemodialysis patients
    Nguyen, TV
    Iacovino, LA
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (18) : 1867 - 1867
  • [30] Regarding "randomized comparison of epoetin alfa and darbepoetin alfa in anemic patients with cancer receiving chemotherapy"
    Nowrousian, Mohammad Resa
    ONCOLOGIST, 2006, 11 (05): : 535 - 536
12345